Skip to main content
Year archive

NGeneBio Co., Ltd. — 2026 filings

All 29 regulatory filings released by NGeneBio Co., Ltd. (354200) in 2026, sourced directly from the official regulator.

29 Filings
2026 Period
2026 filings (29)
Filing Released Lang
증권신고서(지분증권)
Share Issue/Capital Change
2026-05-19 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Q1 2026
2026-05-15 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2026-04-27 Korean
주권매매거래정지 (자본감소)
Regulatory Filings
2026-04-27 Korean
주요사항보고서(감자결정)
Share Issue/Capital Change
2026-04-27 Korean
주주총회소집결의 (임시주주총회)
Proxy Solicitation & Information Statement
2026-04-27 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change
2026-04-27 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2026-04-03 Korean
합병등종료보고서(합병)
M&A Activity
2026-03-31 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2026-03-31 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2026-03-31 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2026-03-31 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2026-03-31 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2026-03-31 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2026-03-31 Korean
사업보고서 (2025.12)
Audit Report / Information FY 2025
2026-03-23 Korean
감사보고서제출
Audit Report / Information FY 2025
2026-03-23 Korean
주주총회소집공고
AGM Information
2026-03-13 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2026-03-13 Korean
[기재정정]주주총회소집결의
Proxy Solicitation & Information Statement
2026-03-13 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2026-03-10 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2025
2026-02-27 Korean
전환청구권행사
Share Issue/Capital Change
2026-02-25 Korean
전환청구권행사
Share Issue/Capital Change
2026-02-06 Korean
전환청구권행사
Share Issue/Capital Change
2026-02-05 Korean
주요사항보고서(자기전환사채매도결정)
Capital/Financing Update
2026-02-03 Korean
[기재정정]기타경영사항(자율공시) (소규모 합병 승인 이사회 결의(주주총회 갈음) 결과 보고)
M&A Activity
2026-01-30 Korean
[기재정정]주요사항보고서(회사합병결정)
M&A Activity
2026-01-30 Korean
[기재정정]회사합병결정(종속회사의주요경영사항)
M&A Activity
2026-01-30 Korean